1. Home
  2. APLS vs CRVL Comparison

APLS vs CRVL Comparison

Compare APLS & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • CRVL
  • Stock Information
  • Founded
  • APLS 2009
  • CRVL 1987
  • Country
  • APLS United States
  • CRVL United States
  • Employees
  • APLS N/A
  • CRVL N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • CRVL Specialty Insurers
  • Sector
  • APLS Health Care
  • CRVL Finance
  • Exchange
  • APLS Nasdaq
  • CRVL Nasdaq
  • Market Cap
  • APLS 2.3B
  • CRVL 1.9B
  • IPO Year
  • APLS 2017
  • CRVL 1991
  • Fundamental
  • Price
  • APLS $17.30
  • CRVL $112.51
  • Analyst Decision
  • APLS Buy
  • CRVL
  • Analyst Count
  • APLS 19
  • CRVL 0
  • Target Price
  • APLS $39.06
  • CRVL N/A
  • AVG Volume (30 Days)
  • APLS 2.7M
  • CRVL 159.3K
  • Earning Date
  • APLS 05-07-2025
  • CRVL 05-21-2025
  • Dividend Yield
  • APLS N/A
  • CRVL N/A
  • EPS Growth
  • APLS N/A
  • CRVL 18.07
  • EPS
  • APLS N/A
  • CRVL 1.70
  • Revenue
  • APLS $775,839,000.00
  • CRVL $871,308,000.00
  • Revenue This Year
  • APLS $12.25
  • CRVL N/A
  • Revenue Next Year
  • APLS $21.08
  • CRVL N/A
  • P/E Ratio
  • APLS N/A
  • CRVL $66.14
  • Revenue Growth
  • APLS 48.04
  • CRVL 12.64
  • 52 Week Low
  • APLS $16.65
  • CRVL $76.53
  • 52 Week High
  • APLS $43.99
  • CRVL $128.61
  • Technical
  • Relative Strength Index (RSI)
  • APLS 34.14
  • CRVL 52.62
  • Support Level
  • APLS $16.65
  • CRVL $109.53
  • Resistance Level
  • APLS $20.75
  • CRVL $114.00
  • Average True Range (ATR)
  • APLS 1.09
  • CRVL 2.85
  • MACD
  • APLS 0.14
  • CRVL 0.03
  • Stochastic Oscillator
  • APLS 15.85
  • CRVL 55.82

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies and government agencies in managing worker's compensation and health, auto and liability services. The company's solutions combine integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

Share on Social Networks: